Genetic study reveals easily-exploitable "chinks in the armor" of MRSA superbugs

Humans are currently locked in an arms race against pathogenic bacteria – and we’re losing. After we developed antibiotics, starting with penicillin in the early 20th century, bacteria have evolved resistance to each new drug we created, thre… Continue reading Genetic study reveals easily-exploitable "chinks in the armor" of MRSA superbugs

Treating brain inflammation could help silence tinnitus

If you’ve ever been kept awake by that ringing in your ears when everything else is quiet, you’d be familiar with how frustrating tinnitus can be. Now, research led by the University of Arizona may have uncovered a new potential treatment tar… Continue reading Treating brain inflammation could help silence tinnitus

Superbug gene that resists "last resort" antibiotics detected in US for the first time

Antibiotics were one of the most important scientific developments of the 20th century, helping to easily control bacterial infections and make previously life-threatening procedures and illnesses safe. But inversely, they might also be one o… Continue reading Superbug gene that resists "last resort" antibiotics detected in US for the first time

Exploiting a newly-discovered weakness in the cold virus opens new antiviral avenue

Viruses can be tricky foes, but researchers in Europe have uncovered a new weakness that could be exploited to produce new antiviral drugs. The team discovered a compound that can prevent certain classes of viruses from infecting cells, pavin… Continue reading Exploiting a newly-discovered weakness in the cold virus opens new antiviral avenue

Scientists discover why a promising cancer drug failed in clinical trials – and how to fix it

As promising as some treatments are in lab tests, unfortunately they don’t always meet hopes when translated to the real world. Now, scientists at Whitehead Institute for Biomedical Research have investigated a class of cancer drugs that fail… Continue reading Scientists discover why a promising cancer drug failed in clinical trials – and how to fix it

Self-powered micro-submarines sink and swim to deliver drugs in the body

It’s entirely possible that micro-machines could one day be delivering drugs inside the body, with many designs proposed in recent years. The latest comes from the University of New South Wales (UNSW), which gets around under its own power us… Continue reading Self-powered micro-submarines sink and swim to deliver drugs in the body

Drug-resistant infections could be starved of nutrients using existing medicines

Microorganisms like bacteria and fungi are increasingly becoming resistant to our best drugs, which is hurtling us towards a terrifying future where once-easily-treated infections become potentially life-threatening again. But now researchers… Continue reading Drug-resistant infections could be starved of nutrients using existing medicines

AI Patent Trolls Now on the Job for Drug Companies

Love it or loathe it, the pharmaceutical industry is really good at protecting its intellectual property. Drug companies pour billions into discovering new drugs and bringing them to market, and they do whatever it takes to make sure they have exclusive positions to profit from their innovations for as long a possible. Patent applications are meticulously crafted to keep the competition at bay for as long as possible, which is why it often takes ages for cheaper generic versions of blockbuster medications to hit the market, to the chagrin of patients, insurers, and policymakers alike.

Drug companies now appear poised …read more

Continue reading AI Patent Trolls Now on the Job for Drug Companies

AI Patent Trolls Now on the Job for Drug Companies

Love it or loathe it, the pharmaceutical industry is really good at protecting its intellectual property. Drug companies pour billions into discovering new drugs and bringing them to market, and they do whatever it takes to make sure they have exclusive positions to profit from their innovations for as long a possible. Patent applications are meticulously crafted to keep the competition at bay for as long as possible, which is why it often takes ages for cheaper generic versions of blockbuster medications to hit the market, to the chagrin of patients, insurers, and policymakers alike.

Drug companies now appear poised …read more

Continue reading AI Patent Trolls Now on the Job for Drug Companies